Centre of Excellence for Commercialization and Research
Potential prostate cancer treatment developed in B.C. gets big boost
A potential treatment for advanced prostate cancer developed by the University of British Columbia (UBC) and Vancouver Coastal Health Research Institute (VCHRI) scientists has been licensed to pharmaceutical company Roche, marking UBC’s largest licensing agreement to date.
Dec 15, 2015